PlushCare, a direct-to-consumer telemedicine service that originally focused on acute and urgent care, has partnered with Thermo Fisher Scientific to add allergy testing to its offerings. PlushCare users will have access to Thermo Fisher's ImmunoCAP Specific IgE blood test, which can detect a number of allergies without needing to subject a patient to the traditional skin prick test.
from MobiHealthNews http://ift.tt/2FMpzyW
March 02, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Novo Nordisk, Sempre Health and other digital health dealsNovo Nordisk and San Francisco-based Sempre Health have announced their collaboration on a pilot program that will offer diabetes medications through the latter company’s monetary incentive and SMS-driven prescription refill … Read More
Digital health news briefs for 4/9/18Need advice? Study says look to the web. A free web-based decision aid that aims to help women with breast cancer make choices about their reconstruction surgery could help save money, according to a new study published in Ps… Read More
Finnish Student Health System, Meru Health and eClinicalHealth team up for depression studyDepression among college students has become a hot topic on university campuses as the number of students seeking treatment for this condition continues to grow. from MobiHealthNews https://ift.tt/2Hb8Qp6 … Read More
NuvoAir to launch its updated smart, wireless spirometer for home useStockholm, Sweden-based respiratory monitor maker NuvoAir (formerly Pond Healthcare Innovation) has unveiled the newest version of its home-use spirometer. Dubbed the Air Next, the small and portable device is connected to us… Read More
FDA's 2019 budget request cites digital health; agency rolls out medical device initiativeDigital health appears to be making its way onto the national stage. Yesterday, FDA Commissioner Scott Gottlieb gave the field a shout-out in his remarks to the US House Subcommittee on Agriculture, Rural Development concerni… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment